Site identity card

Centre Hospitalier Régional et Universitaire de Nancy

Nancy, France
Share

Networks

Clinical Studies (4)

  • HANTA-NE : Study aims to specify kidney damage during hantavirus infection, and risk factors for severe form, and to evaluate the performance of a previously developed prognostic score
  • IMACovid : Study aims to identify and characterize cardiac injury in post COVID patients as an ischemic or non-ischemic pattern, to better assess risk stratification and to guide effective therapies if necessary
  • CoCoPrev : Study aims to assess the impact of monoclonal antibodies and direct antiviral therapies on clinical and virological outcomes in high-risk patients with early mild-to-moderate COVID-19, including sequencing to identify viral population changes and emerging minority variants.
  • Co-SURVIVORS : Study aims to conduct a multidisciplinary assessment of respiratory, cardiac, sleep, and mental health sequelae three months after SARS-CoV-2 diagnosis in order to better characterise these complications

Study Data

  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Fragile population
  • Immunocompromised host
  • Hospital
  • Outpatient clinic
  • SARS-CoV-2
  • Hantavirus
  • Post COVID-19 condition
  • Acute COVID-19
  • Hantavirus infection
  • Pharmacological intervention
  • Monoclonal antibodies
  • Sotrovimab
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to